MA-QUANTORI
27.12.2022 16:44:36 CET | Business Wire | Press release
Quantori, LLC, a leading global provider of data science and digital transformation solutions for life science and healthcare organizations, today announced a partnership with Databricks, the data lakehouse company, to power innovation across the entire drug lifecycle by unifying data, analytics, and AI on a simple and open multi-cloud platform.
“Technology is a key driver of innovation in the life sciences and is transforming pharma R&D,” said Richard Golob, Quantori’s CEO. “We are excited that Quantori has become an official Databricks Consulting Partner to help biopharma customers accelerate their research and improve health outcomes with the power of data and AI. Our data scientists and ML engineers have extensive experience in data migration to the Databricks Lakehouse Platform, plus a deep domain knowledge in life sciences required for facilitating successful RWE studies that increase speed to market.”
Databricks has pioneered a simple and open architecture for data and AI, which brings the reliability, governance, and performance of a data warehouse directly to the data lakes in which most organizations already store their data. Databricks Partners are helping customers build lakehouse platforms on AWS, Microsoft Azure, and Google Cloud to support every data and analytics use case – from data warehousing and business intelligence to data engineering and AI/ML workloads.
“Databricks is a pioneer of the data lakehouse paradigm which tackles the big data challenges in healthcare and life sciences, such as data silos and fragmented patient data and the ability to gain real-time insights to inform treatment decisions,” added Solman Rahman, Quantori’s Executive Vice President for Europe. “Partnering with Databricks supports Quantori’s goal of being the bridge between science and patient success by helping customers streamline the data management lifecycle to accelerate innovation and translate science from the lab to the clinic.”
To learn more about Quantori’s Databricks solutions, visit the Databricks partner page and the Databricks page on Quantori’s website.
About Quantori
Quantori is transforming life sciences and healthcare through the power of digital IT. Quantori develops comprehensive software engineering, scientific informatics, data science, and AI solutions that allow biopharma companies to accelerate each stage of the drug development process and enable healthcare organizations to enhance patient outcomes. Quantori combines data engineering and advanced analytics with deep scientific domain knowledge to help life sciences and healthcare organizations achieve their digital transformations with greater speed and agility. Learn more at www.quantori.com and keep connected on social media @Twitter, @LinkedIn, and Facebook.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221227005198/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing2.9.2026 21:31:00 CEST | Press release
New automated platform is designed to improve the quality, efficiency, and consistency of DNA extraction and concentration from large-volume blood and plasma samples, supporting downstream assays capable of detecting disease-associated signals at MRD sensitivity levels. Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America. First unveiled at the American Association for Cancer Research Annual Meeting in April 2026, PrepQuant is now being delivered to customers, marking the platform's progression from development and validation into commercial deployment. The commercial milestone extends Invivoscribe's capabilities into laboratory instrumentation and addresses a critical bottleneck in highly sensitive molecular testing: efficiently recovering, concentrating, and quantifying DNA from larger blood and plasma inputs. PrepQuant is assay agnostic, de
C.H. Guenther Opens Centre of Excellence in Coventry, UK to Accelerate Bakery Innovation and Support Future Manufacturing Growth Across UK and Europe2.9.2026 18:00:00 CEST | Press release
C.H. Guenther & Son LLC (“C.H. Guenther” or “CHG”), a leading food manufacturer, has opened a new Centre of Excellence (the “Centre”) at its flagship Coventry bakery, creating a dedicated innovation and customer collaboration hub designed to accelerate the development of premium bakery products across the UK and Europe. The new facility has been designed to support CHG’s customers including leading global quick service restaurants, foodservice operators and retailers as they develop, test and refine new bakery products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902696890/en/ The purpose-built, 172-square-metre Centre of Excellence brings together a commercial-scale bakery, customer demonstration kitchen, sensory evaluation facilities, innovation suite and dedicated collaboration spaces in one specialized location. Designed to support and accelerate product development from concept through to commercial manufacturing,
Record Asset Management Enters New Phase of Growth2.9.2026 17:35:00 CEST | Press release
Record Asset Management GmbH (“RAM”), a subsidiary of London-listed Record plc (“Record” or the “Group”), is pleased to announce that it is now operating cashflow positive, thereby marking a transition from its investment phase into a growth business within the Group, and a significant milestone towards sustainable profitability. RAM is the European asset management arm of Record, the London-listed specialist investment group managing USD 122 billion of assets on behalf of institutional clients worldwide. Record's client base comprises pension funds, foundations, sovereign institutions and other asset managers, with whom the Group has built long-standing relationships through its focus on bespoke investment and risk management solutions. RAM was established as a sister company to Record’s core currency business and obtained its BaFin license in 2022. RAM has grown rapidly in the last two years and has developed into a diversified private markets platform with dedicated infrastructure e
Doha Debates Holds Toronto Town Hall on Football, Money and Fandom2.9.2026 17:10:00 CEST | Press release
A sports journalist, a historian and a filmmaker join students from Qatar, Canada and Mexico to debate the impact of wealthy club backing on football and its fans Football fans embody club loyalty that no boardroom can manufacture. But as global capital reshapes the world’s most-watched sport, who it belongs to is increasingly contested. This question is at the heart of Qatar Foundation’s latest Doha Debates town hall, “Football fandom: Community or commodity?”, now available on Doha Debates and Al Jazeera Digital platforms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902833406/en/ Doha Debates Town Hall “Football fandom: Community or commodity?” stage at the Terminal Theatre in Toronto, Canada. (Photo: AETOSWire) The episode was filmed at The Terminal Theatre in Toronto in partnership with the Qatar, Canada and Mexico 2026 Year of Culture, a national initiative that builds lasting relationships between countries by cr
Honoring the World’s Most Exceptional Tourism Destinations: Nominations Now Open for the Second TOURISE Awards2.9.2026 15:55:00 CEST | Press release
The TOURISE Awards showcase the globe's most influential destinations, highlighting the richness of culture, the power of human connection, and groundbreaking advancements in travel. Six categories are open for nominations, including a new award for Best Wellness Destination, plus a flagship Best Overall Destination award selected by the jury. Winners will be honored at the TOURISE Awards ceremony, held in conjunction with the TOURISE Summit in Riyadh, March 23-25, 2027. The second cycle of the TOURISE Awards officially launched today as a continuing global benchmark celebrating premier tourism destinations. The TOURISE Awards set a new global benchmark in 2025, celebrating destinations that deliver distinctive, purpose-driven travel experiences. In 2027, TOURISE will celebrate the destinations shaping tomorrow’s tourism; that deliver value across the entire journey, align with traveler purpose, and set new global standards for how the world travels, connects, and grows. Nominations ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom